Communauté CAPS

Discutez ensemble, ou dites-nous juste ce que vous avez sur le cœur.

Conversations

Choisissez une langue : EN FR TOUTES

Vous devez vous authentifier ou créer un compte pour lancer un sujet.

Vous devez vous authentifier ou créer un compte pour lancer un sujet.

Actualités de la communauté CAPS

  • -

    Canakinumab to Treat Neonatal-Onset Multisystem Inflammatory Disease
    News, publié il y a 6 mois

    Voir la transcription


    Status: Recruiting, Condition Summary: NOMID; CINCA Syndrome

  • -

    Brain multiple sclerosis-like lesions in a patient with Muckle-Wells syndrome
    News, publié il y a 7 mois

    Voir la transcription


    ARTICLE from Rheumotology (via MEDWORM). Muckle-Wells syndrome (MWS) is an autosomal dominant condition with variable penetrance characterized by recurrent fever syndromes, urticarial rash, non-exudative conjunctivitis, myalgia, arthralgia and/or arthritis, chronic headaches and/or increased intracranial pressure, chronic deafness and decreased level of energy [1]. MWS belongs to the group of cryopyrin-associated periodic fever (CAPS) including familial cold

  • -

    Genetics Home Reference: Muckle-Wells syndrome
    News, publié il y a environ 1 an

    Voir la transcription


    (via MEDWORM) Muckle Wells on Genetics Home Reference

  • -

    Efficacy and safety of rilonacept (interleukin-1 trap) in patients with cryopyrin-associated periodic syndromes: Results from two sequential placebo-controlled studies
    News, publié il y a environ 1 an

    Voir la transcription


    To assess the efficacy and safety of rilonacept (Interleukin-1 [IL-1] Trap), a long-acting and potent inhibitor of IL-1, in patients with cryopyrin-associated periodic syndromes (CAPS), including familial cold autoinflammatory syndrome (FCAS) and Muckle-Wells syndrome (MWS).